Ledger.Open graph →
SEC Form D · Amendment · filed October 5, 2016

Aspyrian Therapeutics, Inc

Offering
$56.0M
Sold
$55.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Hiroshi Mori · San Diego, CADirectorMiguel Garcia-Guzman · San Diego, CAExec · DirectorHiroshi Mikitani · New York, NYDirectorMerrill Biel · San Diego, CAExec · DirectorHiroshi Mori · San Diego, CADirectorMiguel Garcia-Guzman · San Diego, CAExec · DirectorHiroshi Mikitani · San Diego, CADirectorMerrill Biel · San Diego, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗